Alaunos Therapeutics (TCRT) Total Current Liabilities (2009 - 2026)
Alaunos Therapeutics (TCRT) reported Total Current Liabilities of $595000.0 for Q1 2026, down 43.97% on a YoY basis from $1.1 million in Q1 2025, and down 26.81% quarter-over-quarter from $813000.0 in Q4 2025.
Alaunos Therapeutics (TCRT) Total Current Liabilities (2009 - 2026) Analysis & Trends
Alaunos Therapeutics has reported Total Current Liabilities for 18 years, with the latest figure at $595000.0 in Q1 2026.
- For the quarter ending Q1 2026, Total Current Liabilities fell 43.97% year-over-year to $595000.0; the trailing twelve-month figure through Mar 2026 stood at $595000.0 (down 43.97% YoY), and the FY2025 full-year result was $813000.0, up 17.49% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $595000.0, down from $813000.0 in the prior quarter.
- The five-year high for Total Current Liabilities was $32.9 million in Q3 2022, with the low at $595000.0 in Q1 2026.
- Historically, Total Current Liabilities has averaged $8.3 million across 5 years, with a median of $1.2 million in 2024.
- Annual changes were most pronounced in 2022 — Total Current Liabilities soared 96.98% — and 2024, when it plunged 92.73%.
- Alaunos Therapeutics' Total Current Liabilities stood at $24.2 million in 2022, then sank by 91.91% to $2.0 million in 2023, then slumped by 64.62% to $692000.0 in 2024, then increased by 17.49% to $813000.0 in 2025, then decreased by 26.81% to $595000.0 in 2026.
- The last three Total Current Liabilities figures came in at $595000.0 (Q1 2026), $813000.0 (Q4 2025), and $921000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.70 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 636.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 13.42 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 3.88 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 72.86 Mn |
| 10 | Alaunos Therapeutics | 4.31 Mn | 3.95 Mn | - | 595,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 595,000.00 |
| Dec 31, 2025 | 813,000.00 |
| Sep 30, 2025 | 921,000.00 |
| Jun 30, 2025 | 1.07 Mn |
| Mar 31, 2025 | 1.06 Mn |
| Dec 31, 2024 | 692,000.00 |
| Sep 30, 2024 | 826,000.00 |
| Jun 30, 2024 | 907,000.00 |
| Mar 31, 2024 | 1.24 Mn |
| Dec 31, 2023 | 1.96 Mn |
| Sep 30, 2023 | 4.68 Mn |
| Jun 30, 2023 | 5.05 Mn |
| Mar 31, 2023 | 17.06 Mn |
| Dec 31, 2022 | 24.17 Mn |
| Sep 30, 2022 | 32.87 Mn |
| Jun 30, 2022 | 26.78 Mn |
| Mar 31, 2022 | 21.23 Mn |
| Dec 31, 2021 | 16.04 Mn |
| Sep 30, 2021 | 28.17 Mn |
| Jun 30, 2021 | 13.59 Mn |